Global Minimally Invasive Gastrointestinal Surgical Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Get Exclusive Sample PDF of this Report Here

Minimally Invasive Gastrointestinal Surgical Systems Market Analysis

The minimally invasive gastrointestinal (MIGS) surgical systems market has witnessed significant growth due to the increasing preference for less invasive procedures, which offer faster recovery times, reduced hospital stays, and minimal scarring. These systems, which include technologies such as laparoscopic surgery and robotic-assisted surgery, are widely used for procedures such as cholecystectomy, colon resection, and bariatric surgery. The growing global prevalence of gastrointestinal diseases, coupled with an aging population, has driven demand for MIGS systems. In addition, advancements in surgical tools, such as high-definition cameras, improved robotic platforms, and real-time imaging, have enhanced the precision and safety of these procedures. Robotic surgery, led by companies such as Intuitive Surgical with its da Vinci system, has revolutionized MIGS, enabling surgeons to perform complex procedures with greater accuracy. Furthermore, the integration of Artificial Intelligence (AI) and machine learning into MIGS systems is poised to enhance decision-making and optimize patient outcomes. The market is also benefitting from rising healthcare expenditure, particularly in regions such as North America and Asia-Pacific, where healthcare systems are investing heavily in advanced surgical technologies. This is expected to drive continued growth in the MIGS market over the forecast period.

Minimally Invasive Gastrointestinal Surgical Systems Market Size

The global minimally invasive gastrointestinal surgical systems market size was valued at USD 12.02 billion in 2024 and is projected to reach USD 22.35 billion by 2032, with a CAGR of 8.06 % during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Minimally Invasive Gastrointestinal Surgical Systems Market Trends

“Increasing Adoption of Robotic-Assisted Surgery”

A key trend in the minimally invasive gastrointestinal surgical systems market is the increasing adoption of robotic-assisted surgery, which is enhancing precision and improving patient outcomes. Robotic systems, such as the da Vinci Surgical System by Intuitive Surgical, allow surgeons to perform complex gastrointestinal procedures, including bariatric surgery, cholecystectomy, and colon resection, with greater accuracy and minimal incisions. This trend is fueled by the growing preference for minimally invasive procedures due to their associated benefits, such as shorter recovery times, reduced risk of infection, and smaller scars. For instance, in colorectal surgeries, robotic systems have been shown to reduce complications and improve recovery time compared to traditional laparoscopic methods. Furthermore, the integration of advanced imaging techniques and Artificial Intelligence (AI) into these robotic systems is further elevating their capabilities. As healthcare systems globally, particularly in North America and Europe, continue to invest in cutting-edge surgical technologies, the market for robotic-assisted MIGS is poised for significant growth in the coming years.

Report Scope and Minimally Invasive Gastrointestinal Surgical Systems Market Segmentation

Get Exclusive Sample PDF of this Report Here

Minimally Invasive Gastrointestinal Surgical Systems Market Definition

Minimally Invasive Gastrointestinal Surgical Systems (MIGS) refer to advanced medical technologies and surgical techniques that allow surgeons to perform gastrointestinal procedures with minimal incisions, leading to reduced trauma, faster recovery times, and less postoperative pain for patients.

Minimally Invasive Gastrointestinal Surgical Systems Market Dynamics

Drivers

• Increasing Prevalence of Gastrointestinal Disorders

The rising prevalence of gastrointestinal disorders is significantly driving the demand for minimally invasive surgeries. For instance, obesity, which affects more than 650 million adults globally according to the World Health Organization (WHO), has led to a surge in bariatric surgeries, a key area for minimally invasive gastrointestinal procedures. Similarly, colorectal cancer, the third most common cancer worldwide, with over 1.9 million new cases diagnosed annually (Global Cancer Observatory, 2020), has increased the need for minimally invasive colon resection and screening procedures. In addition, conditions such as irritable bowel syndrome (IBS), affecting 10-15% of the global population, have further spurred demand for minimally invasive treatments such as endoscopic procedures. As these gastrointestinal diseases become more prevalent, the adoption of minimally invasive surgical systems, which offer quicker recovery, fewer complications, and enhanced precision, continues to rise. This growing demand for effective and less invasive treatments directly contributes to the expanding minimally invasive gastrointestinal surgical systems market.

• Growing Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures is a significant driver of the gastrointestinal surgical systems market, as patients increasingly seek out options that offer quicker recovery times, reduced hospital stays, and less scarring. For instance, laparoscopic surgeries for conditions such as gallbladder removal (cholecystectomy) and colon resection have become the standard due to their ability to minimize incision sizes and accelerate healing compared to traditional open surgeries. Studies have shown that patients who undergo minimally invasive surgeries experience fewer complications and a faster return to normal activities, making these procedures highly appealing. In bariatric surgery, for instance, minimally invasive techniques such as laparoscopic sleeve gastrectomy allow patients to achieve weight loss goals with minimal disruption to their daily lives. As patient preferences shift towards these benefits, healthcare providers and hospitals are increasingly adopting advanced minimally invasive surgical technologies, propelling the growth of the minimally invasive gastrointestinal surgical systems market.

Opportunities

• Growing Technological Advancements in Surgical Tools

Technological advancements in surgical tools have significantly improved the precision, safety, and effectiveness of gastrointestinal surgeries, creating a major market opportunity. High-definition cameras, for instance, provide surgeons with enhanced visualization during procedures, enabling them to navigate with greater accuracy. Robotic systems, such as the da Vinci Surgical System, offer improved dexterity, precision, and control, allowing for minimally invasive surgeries such as colon resections and cholecystectomies to be performed with greater confidence. Real-time imaging, including 3D visualization and augmented reality, enhances surgical planning and decision-making, reducing the risk of errors and improving patient outcomes. These innovations are increasing the demand for minimally invasive procedures and opening new avenues for market growth, as healthcare providers and surgical centers invest in these advanced technologies to offer the best possible care. As these technological solutions continue to evolve and become more widely adopted, they represent a significant growth driver for the minimally invasive gastrointestinal surgical systems market.

• Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure, particularly in emerging markets, is creating significant opportunities for the growth of the minimally invasive gastrointestinal surgical systems market. As countries such as China, India, and Brazil invest in improving their healthcare systems, there is greater access to advanced surgical technologies such as robotic-assisted surgery and laparoscopic equipment. For instance, India has seen a rapid increase in the number of hospitals adopting minimally invasive techniques, driven by both government initiatives and private sector investments. This shift is helping to address the rising demand for surgical procedures while ensuring that patients benefit from shorter recovery times and reduced complications. Moreover, the availability of these advanced technologies in emerging markets is also reducing the treatment gap between developed and developing nations, promoting more widespread use of minimally invasive surgeries. With healthcare infrastructure continuing to expand in these regions, the demand for advanced gastrointestinal surgical systems is expected to grow, creating a substantial market opportunity for manufacturers and healthcare providers alike.

Restraints/Challenges

• High Equipment Costs

The high cost of equipment is one of the most significant barriers in the minimally invasive gastrointestinal (GI) surgical systems market, as advanced surgical technologies such as robotic systems, laparoscopes, and specialized instruments require substantial initial investment. For instance, the cost of a robotic surgical system, such as the da Vinci Surgical System, can exceed several million dollars, making it difficult for smaller hospitals or surgical centers, particularly in resource-constrained settings, to adopt this technology. This high upfront cost is compounded by the need for ongoing maintenance, training, and the purchase of disposable instruments, further raising the overall cost of implementation. In developing regions where healthcare budgets are limited, this financial burden prevents the widespread adoption of these cutting-edge systems, leading to unequal access to minimally invasive surgery. As a result, many hospitals may continue to rely on traditional open surgeries, which are more affordable in the short term but can result in longer recovery times and higher overall healthcare costs. This high cost of equipment presents a significant market challenge, hindering the growth and accessibility of minimally invasive GI surgical systems, especially in low- and middle-income countries.

• Patient Risks and Complications

While minimally invasive surgeries are generally considered safer and less traumatic than traditional open surgeries, patient risks and complications remain a significant concern, potentially hindering the growth of the minimally invasive GI surgical systems market. Although the incidence of complications such as infections, bleeding, or organ injury is lower compared to open surgeries, the risk still exists, especially if the procedure is not performed correctly or if the patient has underlying health conditions, such as obesity or cardiovascular disease. For instance, laparoscopic cholecystectomy, a common minimally invasive procedure for gallbladder removal, can lead to complications such as bile duct injury or bleeding if the procedure is not carried out precisely, requiring additional intervention or a conversion to open surgery. These risks, though rare, can affect patient outcomes, leading to longer hospital stays, increased costs, or even fatalities, which in turn could reduce the confidence of healthcare providers and patients in adopting these technologies. The possibility of complications thus remains a key challenge in the market, as it may result in hesitation among surgeons, hospital administrators, and patients to fully embrace minimally invasive approaches, especially in complex or high-risk cases.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Minimally Invasive Gastrointestinal Surgical Systems Market Scope

The market is segmented on the basis of product type, surgery, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)
• Surgical Robotics
• Others

Surgery

• Adrenalectomy
• Appendectomy
• Bariatric Surgery
• Cholecystectomy
• Colon and Rectal Surgery
• Foregut Surgery
• Hernia Repair

End-User

• Conventional Technologies
• Surgical Robotics

Minimally Invasive Gastrointestinal Surgical Systems Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, surgery, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the minimally invasive gastrointestinal surgical systems market, driven by the growing geriatric population, advancements in minimally invasive surgery devices, increased healthcare expenditure, and improved healthcare outcomes in the region. This market is also expected to experience substantial growth during the forecast period.

Asia Pacific is anticipated to experience the highest compound annual growth rate (CAGR) in the global minimally invasive gastrointestinal surgical systems market. This growth is fueled by the region's expanding healthcare infrastructure, increasing adoption of advanced surgical technologies, and a rising focus on improving healthcare outcomes. In addition, the growing prevalence of gastrointestinal disorders, along with a large and aging population, further drives demand for minimally invasive procedures. As healthcare spending continues to rise in countries such as China, India, and Japan, the market for minimally invasive surgical systems in this region is set to grow rapidly in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Minimally Invasive Gastrointestinal Surgical Systems Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Minimally Invasive Gastrointestinal Surgical Systems Market Leaders Operating in the Market Are:

• Medtronic (Ireland)
• Stryker (U.S.)
• Smith + Nephew (U.K.)
• Abbott (U.S.)
• Applied Biomedical, LLC (U.S.)
• California Resources Corporation (U.S.)
• Microline Surgical (U.S.)
• Zimmer Biomet (U.S.)
• B. Braun SE (Germany)
• CONMED Corporation (U.S.)
• HOYA Corporation (Japan)
• Applied Medical Resources Corporation (U.S.)
• Aesculap, Inc. (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Karl Storz GmbH & Co. KG (Germany)
• Teleflex Incorporated (U.S.)
• Boston Scientific Corporation (U.S.)

Latest Developments in Minimally Invasive Gastrointestinal Surgical Systems Market

• In May 2024, Intuitive received FDA clearance for its fifth-generation robotic system, the da Vinci 5, marking a significant advancement in robotic-assisted surgery technology
• In January 2024, Boston Scientific Corporation entered into an agreement to acquire Axonics, Inc., enabling the company to expand into sacral neuromodulation and enhance patient access to care in this growing field
• In November 2023, Medtronic received approval from the U.S. Food and Drug Administration (FDA) for its Symplicity Spyral renal denervation (RDN) system, also known as the Simplicity blood pressure procedure, designed to treat hypertension
• In November 2023, Johnson & Johnson MedTech announced that its MONARCH Platform and MONARCH Bronchoscope received regulatory approval in China
• In December 2023, EndoQuest Robotics, Inc. successfully closed a USD 42 million C-1 preferred financing round, allowing further development of their flexible endoluminal robot to revolutionize minimally invasive surgeries

SKU-63238